πŸ‡ΊπŸ‡Έ FDA
Patent

US 8883788

Fused heterocyclic ring compound

granted A61KA61K31/00A61K9/2018

Quick answer

US patent 8883788 (Fused heterocyclic ring compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/00, A61K9/2018, A61K9/2059, A61P